Try
NEOGENOMICS INC
NEOUnited States
103 filed reports · 728 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
103 reports · Dec 2012 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 274 guidance figures, 9 commentary passages.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 48 | 290 | Dec 2012 to Jun 2026 |
| Quarterly · 10-QSEC EDGAR | 41 | 6,481 | Mar 2013 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 13 | 6,456 | Dec 2012 to Dec 2025 |
| Annual · 10-K/ASEC EDGAR | 1 | 377 | Dec 2015 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Jul 28, 2026 | 378 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Jul 28, 2026 | 6 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | Apr 28, 2026 | 6 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | Apr 28, 2026 | 204 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 17, 2026 | 919 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 17, 2026 | 6 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Oct 28, 2025 | 260 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Oct 28, 2025 | 6 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Jul 29, 2025 | 153 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Jul 29, 2025 | 6 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | Apr 29, 2025 | 6 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | Apr 29, 2025 | 150 | Open |
Financial data
728 concepts · 13,604 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial689 concepts · 12,462 facts · Mar 2011 to Jul 2026
- Gross profit (US GAAP)78 · Mar 2011 to Jun 2026
- Net income loss78 · Mar 2011 to Jun 2026
- Revenue78 · Mar 2011 to Jun 2026
- Cash and cash equivalents at carrying value74 · Dec 2011 to Jun 2026
- General and administrative expense (US GAAP)74 · Dec 2011 to Jun 2026
- Operating expenses (US GAAP)74 · Dec 2011 to Jun 2026
- Operating income loss74 · Dec 2011 to Jun 2026
- Research and development expense74 · Dec 2011 to Jun 2026
- Selling and marketing expense (US GAAP)74 · Dec 2011 to Jun 2026
- Amortization of intangible assets73 · Mar 2012 to Jun 2026
- Depreciation73 · Dec 2011 to Jun 2026
- Increase decrease in accounts payable and other operating liabilities73 · Dec 2011 to Jun 2026
- Increase decrease in accounts receivable73 · Dec 2011 to Jun 2026
- Increase decrease in inventories73 · Dec 2011 to Jun 2026
- Payments to acquire property plant and equipment73 · Dec 2011 to Jun 2026
- Weighted average number of diluted shares outstanding72 · Mar 2011 to Jun 2026
- Weighted average number of shares outstanding basic72 · Mar 2011 to Jun 2026
- Accounts payable current71 · Dec 2011 to Jun 2026
- Accounts receivable net current71 · Dec 2011 to Jun 2026
- Accumulated depreciation depletion and amortization property plant and equipment71 · Dec 2011 to Jun 2026
- Additional paid in capital common stock71 · Dec 2011 to Jun 2026
- Assets71 · Dec 2011 to Jun 2026
- Assets current71 · Dec 2011 to Jun 2026
- Common stock par or stated value per share71 · Dec 2011 to Jun 2026
Segment30 concepts · 777 facts · Dec 2015 to Jun 2026
- Revenue289 · Dec 2015 to Jun 2026
- Gross profit (US GAAP)78 · Dec 2015 to Sep 2024
- Cost of goods and services sold (US GAAP)60 · Dec 2016 to Sep 2024
- Goodwill46 · Dec 2017 to Sep 2024
- Clinical Services33 · Mar 2021 to Sep 2024
- Cost of revenue (US GAAP)30 · Mar 2017 to Mar 2022
- Adjustment for amortization14 · Dec 2022 to Jun 2026
- Allocated share based compensation expense14 · Dec 2022 to Jun 2026
- Depreciation14 · Dec 2022 to Jun 2026
- Income tax expense benefit14 · Dec 2022 to Jun 2026
- Interest expense nonoperating14 · Dec 2022 to Jun 2026
- Investment income interest14 · Dec 2022 to Jun 2026
- Net income loss14 · Dec 2022 to Jun 2026
- Operating income loss14 · Dec 2022 to Jun 2026
- Other cost of operating revenue14 · Dec 2022 to Jun 2026
- Other general and administrative expense14 · Dec 2022 to Jun 2026
- Other nonoperating income expense14 · Dec 2022 to Jun 2026
- Research and development expense14 · Dec 2022 to Jun 2026
- Selling and marketing expense (US GAAP)14 · Dec 2022 to Jun 2026
- Income loss from continuing operations before income taxes extraordinary items noncontrolling interest12 · Dec 2022 to Jun 2026
- Share based compensation12 · Mar 2023 to Sep 2024
- Restructuring costs and asset impairment charges10 · Dec 2022 to Sep 2025
- Cost of services6 · Dec 2015 to Dec 2017
- Asset impairment charges5 · Jun 2024 to Jun 2026
Guidance6 concepts · 290 facts · Feb 2013 to Oct 2026
- Revenue Guidance110 · Feb 2013 to Oct 2026
- EPS (Diluted) Guidance96 · Feb 2013 to Jul 2026
- Net Income Guidance62 · Apr 2016 to Jul 2026
- EPS (Diluted) Guidance (Adjusted (non-GAAP))10 · Jul 2018 to Aug 2023
- Net Income Guidance (Adjusted (non-GAAP))8 · Jul 2018 to Feb 2022
- Revenue Growth Guidance4 · Jan 2015 to Aug 2023
Product2 concepts · 64 facts · Dec 2017 to Jun 2026
- Revenue55 · Dec 2022 to Jun 2026
- Cost of goods and services sold (US GAAP)9 · Dec 2017 to Dec 2025
Geography1 concepts · 11 facts · Mar 2020 to Dec 2022
- Minimum lease payments for leases executed but not yet commenced11 · Mar 2020 to Dec 2022
Segments
852 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments7 members · 777 facts
- Clinical Services331 · Dec 2015 to Sep 2024
- Reportable231 · Dec 2022 to Jun 2026
- Pharma Services111 · Dec 2015 to Mar 2024
- Advanced Diagnostics57 · Dec 2021 to Sep 2024
- Clinical services23 · Mar 2017 to Sep 2024
- Pharma services15 · Dec 2017 to Mar 2023
- Advanced diagnostics9 · Dec 2022 to Sep 2024
Product or service5 members · 64 facts
- Client Direct Billing14 · Dec 2022 to Jun 2026
- Commercial Insurance14 · Dec 2022 to Jun 2026
- Medicare And Other Governmental14 · Dec 2022 to Jun 2026
- Self Pay Services13 · Dec 2022 to Jun 2026
- Shipping And Handling9 · Dec 2017 to Dec 2025
Statement geographical1 member · 11 facts
- FL11 · Mar 2020 to Dec 2022
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary9 claims from 1 reports · Oct 2026
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.